Role of exonic variation in chemokine receptor genes on AIDS: CCRL2 F167Y association with pneumocystis pneumonia

PLoS Genetics

Volumn 7, Issue 10, 2011, Pages

  An, Ping ^a   Li, Rongling ^b   Wang, Ji Ming ^c   Yoshimura, Teizo ^c   Takahashi, Munehisa ^c   Samudralal, Ram ^d   O'Brien, Stephen J ^c   Phair, John ^e   Goedert, James J ^f   Kirk, Gregory D ^g   Troyer, Jennifer L ^a   Sezgin, Efe ^c   Buchbinder, Susan P ^h   Donfield, Sharyne ⁱ   Nelson, George W ^a   Winkler, Cheryl A ^a  

^a SAIC FREDERICK INC   (United States)

^b NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^e NORTHWESTERN UNIVERSITY   (United States)

^f NATIONAL CANCER INSTITUTE   (United States)

^g JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^h SAN FRANCISCO DEPARTMENT OF PUBLIC HEALTH   (United States)

ⁱ Rho   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CCR2 GENE; CCR3 GENE; CCR5 GENE; CCR8 GENE; CCRL2 GENE; CELL MIGRATION; CONTROLLED STUDY; CX3CR1 GENE; CXCR6 GENE; DENDRITIC CELL; DISEASE COURSE; EXON; GENE FUNCTION; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; IMMUNOREGULATION; OUTCOME ASSESSMENT; PNEUMOCYSTIS PNEUMONIA; RECEPTOR GENE; SINGLE NUCLEOTIDE POLYMORPHISM; CELL STRAIN HEK293; CHEMISTRY; CHROMOSOME 3; COHORT ANALYSIS; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS 1; SURVIVAL; TREATMENT OUTCOME;

HUMAN IMMUNODEFICIENCY VIRUS 1; PNEUMOCYSTIS;

CCR3 PROTEIN, HUMAN; CCR8 PROTEIN, HUMAN; CCRL2 PROTEIN, HUMAN; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR; CHEMOKINE RECEPTOR CCR3; CHEMOKINE RECEPTOR CCR8; CXCR6 PROTEIN, HUMAN; VIRUS RECEPTOR;

ACQUIRED IMMUNODEFICIENCY SYNDROME; CHROMOSOMES, HUMAN, PAIR 3; COHORT STUDIES; DISEASE PROGRESSION; EXONS; GENETIC ASSOCIATION STUDIES; HEK293 CELLS; HIV-1; HUMANS; LINKAGE DISEQUILIBRIUM; PNEUMONIA, PNEUMOCYSTIS; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, CCR; RECEPTORS, CCR3; RECEPTORS, CCR8; RECEPTORS, CHEMOKINE; RECEPTORS, VIRUS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 80055087630     PISSN: 15537390     EISSN: 15537404     Source Type: Journal    
DOI: 10.1371/journal.pgen.1002328     Document Type: Article

References (75)

1. Carrington M, Nelson GW, Martin MP, Kissner T, Vlahov D, et al. (1999) HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage. Science 283: 1748-1752.
2. O'Brien SJ, Nelson GW, (2004) Human genes that limit AIDS. Nat Genet 36: 565-574.
3. Fellay J, Shianna KV, Ge D, Colombo S, Ledergerber B, et al. (2007) A whole-genome association study of major determinants for host control of HIV-1. Science 317: 944-947.
4. An P, Winkler CA, (2010) Host genes associated with HIV/AIDS: advances in gene discovery. Trends Genet 26: 119-131.
5. Fellay J, Ge D, Shianna KV, Colombo S, Ledergerber B, et al. (2009) Common genetic variation and the control of HIV-1 in humans. PLoS Genet 5: e1000791 doi:10.1371/journal.pgen.1000791.
6. Limou S, Le Clerc S, Coulonges C, Carpentier W, Dina C, et al. (2009) Genomewide association study of an AIDS-nonprogression cohort emphasizes the role played by HLA genes (ANRS Genomewide Association Study 02). J Infect Dis 199: 419-426.
7. Herbeck JT, Gottlieb GS, Winkler CA, Nelson GW, An P, et al. (2010) Multistage genomewide association study identifies a locus at 1q41 associated with rate of HIV-1 disease progression to clinical AIDS. J Infect Dis 201: 618-626.
8. Pereyra F, Jia X, McLaren PJ, Telenti A, de Bakker PI, et al. (2010) The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. Science 330: 1551-1557.
9. Deng H, Liu R, Ellmeier W, Choe S, Unutmaz D, et al. (1996) Identification of a major co-receptor for primary isolates of HIV-1. Nature 381: 661-666.
10. Alkhatib G, Combadiere C, Broder CC, Feng Y, Kennedy PE, et al. (1996) CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 272: 1955-1958.
11. Berger EA, Murphy PM, Farber JM, (1999) Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. Annu Rev Immunol 17: 657-700.
12. Ioannidis JP, Rosenberg PS, Goedert JJ, Ashton LJ, Benfield TL, et al. (2001) Effects of CCR5-Delta32, CCR2-64I, and SDF-1 3′A alleles on HIV-1 disease progression: An international meta-analysis of individual-patient data. Ann Intern Med 135: 782-795.
13. O'Brien SJ, Moore JP, (2000) The effect of genetic variation in chemokines and their receptors on HIV transmission and progression to AIDS. Immunol Rev 177: 99-111.
14. Dean M, Carrington M, Winkler C, Huttley GA, Smith MW, et al. (1996) Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study. Science 273: 1856-1862.
15. Martin MP, Dean M, Smith MW, Winkler C, Gerrard B, et al. (1998) Genetic acceleration of AIDS progression by a promoter variant of CCR5. Science 282: 1907-1911.
16. McDermott DH, Zimmerman PA, Guignard F, Kleeberger CA, Leitman SF, et al. (1998) CCR5 promoter polymorphism and HIV-1 disease progression. Multicenter AIDS Cohort Study (MACS). Lancet 352: 866-870.
17. An P, Martin MP, Nelson GW, Carrington M, Smith MW, et al. (2000) Influence of CCR5 promoter haplotypes on AIDS progression in African-Americans. AIDS 14: 2117-2122.
18. Liu H, Chao D, Nakayama EE, Taguchi H, Goto M, et al. (1999) Polymorphism in RANTES chemokine promoter affects HIV-1 disease progression. Proc Natl Acad Sci U S A 96: 4581-4585.
19. An P, Nelson GW, Wang L, Donfield S, Goedert JJ, et al. (2002) Modulating influence on HIV/AIDS by interacting RANTES gene variants. Proc Natl Acad Sci U S A 99: 10002-10007.
20. Huang Y, Paxton WA, Wolinsky SM, Neumann AU, Zhang L, et al. (1996) The role of a mutant CCR5 allele in HIV-1 transmission and disease progression. Nat Med 2: 1240-1243.
21. Samson M, Libert F, Doranz BJ, Rucker J, Liesnard C, et al. (1996) Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 382: 722-725.
22. Liu R, Paxton WA, Choe S, Ceradini D, Martin SR, et al. (1996) Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 86: 367-377.
23. Gonzalez E, Bamshad M, Sato N, Mummidi S, Dhanda R, et al. (1999) Race-specific HIV-1 disease-modifying effects associated with CCR5 haplotypes. Proc Natl Acad Sci U S A 96: 12004-12009.
24. Winkler CA, Hendel H, Carrington M, Smith MW, Nelson GW, et al. (2004) Dominant effects of CCR2-CCR5 haplotypes in HIV-1 disease progression. J Acquir Immune Defic Syndr 37: 1534-1538.
25. Kostrikis LG, Neumann AU, Thomson B, Korber BT, McHardy P, et al. (1999) A polymorphism in the regulatory region of the CC-chemokine receptor 5 gene influences perinatal transmission of human immunodeficiency virus type 1 to African-American infants. J Virol 73: 10264-10271.
26. Rucker J, Edinger AL, Sharron M, Samson M, Lee B, et al. (1997) Utilization of chemokine receptors, orphan receptors, and herpesvirus-encoded receptors by diverse human and simian immunodeficiency viruses. J Virol 71: 8999-9007.
27. Alkhatib G, Liao F, Berger EA, Farber JM, Peden KW, (1997) A new SIV co-receptor, STRL33. Nature 388: 238.
28. Smith MW, Dean M, Carrington M, Winkler C, Huttley GA, et al. (1997) Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC), ALIVE Study. Science 277: 959-965.
29. Mummidi S, Ahuja SS, Gonzalez E, Anderson SA, Santiago EN, et al. (1998) Genealogy of the CCR5 locus and chemokine system gene variants associated with altered rates of HIV-1 disease progression. Nat Med 4: 786-793.
30. Duggal P, An P, Beaty TH, Strathdee SA, Farzadegan H, et al. (2003) Genetic influence of CXCR6 chemokine receptor alleles on PCP-mediated AIDS progression among African Americans. Genes Immun 4: 245-250.
31. Limou S, Coulonges C, Herbeck JT, van Manen D, An P, et al. (2010) Multiple-cohort genetic association study reveals CXCR6 as a new chemokine receptor involved in long-term nonprogression to AIDS. J Infect Dis 202: 908-915.
32. Daugherty BL, Springer MS, (1997) The beta-chemokine receptor genes CCR1 (CMKBR1), CCR2 (CMKBR2), and CCR3 (CMKBR3) cluster within 285 kb on human chromosome 3p21. Genomics 41: 294-295.
33. Choe H, Farzan M, Sun Y, Sullivan N, Rollins B, et al. (1996) The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 85: 1135-1148.
34. Choe H, Farzan M, Konkel M, Martin K, Sun Y, et al. (1998) The orphan seven-transmembrane receptor apj supports the entry of primary T-cell-line-tropic and dualtropic human immunodeficiency virus type 1. J Virol 72: 6113-6118.
35. Scarlatti G, Tresoldi E, Bjorndal A, Fredriksson R, Colognesi C, et al. (1997) In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression. Nat Med 3: 1259-1265.
36. Nedellec R, Coetzer M, Shimizu N, Hoshino H, Polonis VR, et al. (2009) Virus entry via the alternative coreceptors CCR3 and FPRL1 differs by human immunodeficiency virus type 1 subtype. J Virol 83: 8353-8363.
37. Lusso P, (2006) HIV and the chemokine system: 10 years later. EMBO J 25: 447-456.
38. Xiao L, Rudolph DL, Owen SM, Spira TJ, Lal RB, (1998) Adaptation to promiscuous usage of CC and CXC-chemokine coreceptors in vivo correlates with HIV-1 disease progression. AIDS 12: F137-143.
39. Connor RI, Sheridan KE, Ceradini D, Choe S, Landau NR, (1997) Change in coreceptor use coreceptor use correlates with disease progression in HIV-1-infected individuals. J Exp Med 185: 621-628.
40. Shimizu N, Tanaka A, Oue A, Mori T, Ohtsuki T, et al. (2009) Broad usage spectrum of G protein-coupled receptors as coreceptors by primary isolates of HIV. AIDS 23: 761-769.
41. Gorry PR, Dunfee RL, Mefford ME, Kunstman K, Morgan T, et al. (2007) Changes in the V3 region of gp120 contribute to unusually broad coreceptor usage of an HIV-1 isolate from a CCR5 Delta32 heterozygote. Virology 362: 163-178.
42. Cilliers T, Willey S, Sullivan WM, Patience T, Pugach P, et al. (2005) Use of alternate coreceptors on primary cells by two HIV-1 isolates. Virology 339: 136-144.
43. Carrington M, Dean M, Martin MP, O'Brien SJ, (1999) Genetics of HIV-1 infection: chemokine receptor CCR5 polymorphism and its consequences. Hum Mol Genet 8: 1939-1945.
44. Hendel H, Winkler C, An P, Roemer-Binns E, Nelson G, et al. (2001) Validation of genetic case-control studies in AIDS and application to the CX3CR1 polymorphism. J Acquir Immune Defic Syndr 26: 507-511.
45. Thomson G, Barcellos LF, Valdes AM, (2008) Searching for additional disease loci in a genomic region. Adv Genet 60: 253-292.
46. Cordell HJ, Clayton DG, (2002) A unified stepwise regression procedure for evaluating the relative effects of polymorphisms within a gene using case/control or family data: application to HLA in type 1 diabetes. Am J Hum Genet 70: 124-141.
47. Holm S, (1979) A Simple Sequentially Rejective Bonferroni Test Procedure. Scand J Stat 6: 65-70.
48. Harrell FE Jr, Lee KL, Mark DB, (1996) Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 15: 361-387.
49. Yoshimura T, Oppenheim JJ, (2008) Chemerin reveals its chimeric nature. J Exp Med 205: 2187-2190.
50. Arai M, Mitsuke H, Ikeda M, Xia JX, Kikuchi T, et al. (2004) ConPred II: a consensus prediction method for obtaining transmembrane topology models with high reliability. Nucleic Acids Res 32: W390-393.
51. Leick M, Catusse J, Follo M, Nibbs RJ, Hartmann TN, et al. (2009) CCL19 is a specific ligand of the constitutively recycling atypical human chemokine receptor CRAM-B. Immunology 129: 536-546.
52. Zabel BA, Nakae S, Zuniga L, Kim JY, Ohyama T, et al. (2008) Mast cell-expressed orphan receptor CCRL2 binds chemerin and is required for optimal induction of IgE-mediated passive cutaneous anaphylaxis. J Exp Med 205: 2207-2220.
53. Lee S, Tiffany HL, King L, Murphy PM, Golding H, et al. (2000) CCR8 on human thymocytes functions as a human immunodeficiency virus type 1 coreceptor. J Virol 74: 6946-6952.
54. Galligan CL, Matsuyama W, Matsukawa A, Mizuta H, Hodge DR, et al. (2004) Up-regulated expression and activation of the orphan chemokine receptor, CCRL2, in rheumatoid arthritis. Arthritis Rheum 50: 1806-1814.
55. Thomas CF Jr, Limper AH, (2004) Pneumocystis Pneumonia. N Engl J Med 350: 2487-2498.
56. Hartmann TN, Leick M, Ewers S, Diefenbacher A, Schraufstatter I, et al. (2008) Human B cells express the orphan chemokine receptor CRAM-A/B in a maturation-stage-dependent and CCL5-modulated manner. Immunology 125: 252-262.
57. Oostendorp J, Hylkema MN, Luinge M, Geerlings M, Meurs H, et al. (2004) Localization and enhanced mRNA expression of the orphan chemokine receptor L-CCR in the lung in a murine model of ovalbumin-induced airway inflammation. J Histochem Cytochem 52: 401-410.
58. Otero K, Vecchi A, Hirsch E, Kearley J, Vermi W, et al. (2010) Non-redundant role of CCRL2 in lung dendritic cell trafficking. Blood 116: 2942-2949.
59. Phair J, Jacobson L, Detels R, Rinaldo C, Saah A, et al. (1992) Acquired immune deficiency syndrome occurring within 5 years of infection with human immunodeficiency virus type-1: the Multicenter AIDS Cohort Study. J Acquir Immune Defic Syndr 5: 490-496.
60. Buchbinder SP, Katz MH, Hessol NA, O'Malley PM, Holmberg SD, (1994) Long-term HIV-1 infection without immunologic progression. AIDS 8: 1123-1128.
61. Vlahov D, Graham N, Hoover D, Flynn C, Bartlett JG, et al. (1998) Prognostic indicators for AIDS and infectious disease death in HIV-infected injection drug users: plasma viral load and CD4+ cell count. JAMA 279: 35-40.
62. Hilgartner MW, Donfield SM, Willoughby A, Contant CF Jr, Evatt BL, et al. (1993) Hemophilia growth and development study. Design, methods, and entry data. Am J Pediatr Hematol Oncol 15: 208-218.
63. Goedert JJ, Kessler CM, Aledort LM, Biggar RJ, Andes WA, et al. (1989) A prospective study of human immunodeficiency virus type 1 infection and the development of AIDS in subjects with hemophilia. N Engl J Med 321: 1141-1148.
64. Celentano DD, Vlahov D, Cohn S, Shadle VM, Obasanjo O, et al. (1998) Self-reported antiretroviral therapy in injection drug users. JAMA 280: 544-546.
65. Faure S, Meyer L, Costagliola D, Vaneensberghe C, Genin E, et al. (2000) Rapid progression to AIDS in HIV+ individuals with a structural variant of the chemokine receptor CX3CR1. Science 287: 2274-2277.
66. Centers for Disease Control (1987) Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. Council of State and Territorial Epidemiologists; AIDS Program, Center for Infectious Diseases. MMWR Morb Mortal Wkly Rep 36 (Suppl 1): 1S-15S.
67. Kaslow RA, Carrington M, Apple R, Park L, Munoz A, et al. (1996) Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection. Nat Med 2: 405-411.
68. Gao X, Nelson GW, Karacki P, Martin MP, Phair J, et al. (2001) Effect of a single amino acid change in MHC class I molecules on the rate of progression to AIDS. N Engl J Med 344: 1668-1675.
69. Shtatland ES, Kleinman K, Cain EM, (2005) Model Building in PROC PHREG with Automatic Variable Selection and Information Criteria. pp. 1-10 Proceedings of the 30th Annual SAS Users Group International Conference Paper 206-30.
70. Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, et al. (2006) Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 38: 904-909.
71. Troyer JL, Nelson GW, Lautenberger JA, Chinn L, McIntosh C, et al. (2011) Genome-wide association study implicates PARD3B-based AIDS restriction. J Infect Dis 203: 1491-1502.
72. Allison PD, (1995) Survival Analysis Using the SAS System: A Practical Guide Cary, NC SAS Institute Inc.
73. Lewontin RC, (1964) The Interaction of Selection and Linkage. II. Optimum Models. Genetics 50: 757-782.
74. Hung LH, Ngan SC, Liu T, Samudrala R, (2005) PROTINFO: new algorithms for enhanced protein structure predictions. Nucleic Acids Res 33: W77-80.
75. Hung LH, Samudrala R, (2003) PROTINFO: Secondary and tertiary protein structure prediction. Nucleic Acids Res 31: 3296-3299.